Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-centered analysis of preoperative information before genital feminizing surgery: a multicenter French mixed-methods study.

The journal of sexual medicine·2026
Same author

Indocyanine green use, detection and safety in patients with breast cancer undergoing sentinel lymph node biopsy: A French prospective observational study.

Surgical oncology·2026
Same author

Comparative study of two protocols of induction of labor with DILAPAN-S devices in a situation of intra-uterine fetal death or medical termination of pregnancy.

Journal of gynecology obstetrics and human reproduction·2026
Same author

Corrigendum to 'Episiotomy to prevent obstetric anal sphincter injuries during instrumental delivery in nulliparous women: a national prospective comparative cohort study' [American Journal of Obstetrics and Gynecology 233/2 (2025) 123-124].

American journal of obstetrics and gynecology·2026
Same author

Adoption of robot-assisted surgery for hysterectomy in France: a nationwide analysis of surgical routes and length of hospital stay (2020-2024).

Journal of robotic surgery·2026
Same author

Robotic single-port (SP) vaginal hysterectomy: the first cases in Europe and surgical steps.

Surgical endoscopy·2026

Related Experiment Videos

[Antithrombotic therapy and pregnancy].

Céline Chauleur1, Tiphaine Raia, Jean-Christophe Gris

  • 1CHU de Saint-Étienne, hôpital Nord, département d'obstétrique et gynécologie, 42270 Saint-Priest-en-Jarez, France; Université Jean-Monnet, EA 3065 groupe de recherche sur la thrombose, Saint-Étienne, France.

Presse Medicale (Paris, France : 1983)
|July 17, 2013
PubMed
Summary
This summary is machine-generated.

Pregnancy complications like venous thromboembolism (VTE) and placenta-mediated issues (PC) affect many women. Identifying risk factors and using treatments like LMWH and aspirin can improve pregnancy outcomes.

Related Experiment Videos

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Pharmacology

Context:

  • Venous thromboembolism (VTE) affects approximately 1 in 1000 pregnancies.
  • Placenta-mediated pregnancy complications (PC) occur in 15% of pregnancies.
  • Understanding risk factors is crucial for preventing adverse pregnancy outcomes.

Purpose:

  • To highlight the incidence of VTE and PC during pregnancy.
  • To emphasize the importance of identifying biological and clinical risk factors for VTE and PC.
  • To discuss current antithrombotic therapies, including low molecular weight heparin (LMWH) and aspirin, as treatments of choice.

Summary:

  • VTE and PC represent significant risks during pregnancy.
  • Risk assessment for VTE and PC is recommended for all pregnant women.
  • LMWH and aspirin are key pharmacological interventions for managing these conditions.

Impact:

  • Improved risk stratification can lead to targeted preventive strategies.
  • Timely and appropriate antithrombotic therapy can reduce maternal morbidity and mortality.
  • Enhanced understanding of risk factors and treatment options will optimize maternal and fetal outcomes.